School of Medicine
Showing 1-10 of 109 Results
-
Moiz Ahmad
Postdoctoral Research fellow, Radiation Physics
Bio I attended primary and secondary school in Houston, TX, USA. I attended The University of Texas - Austin from 2001-2005 where I double-majored in Electrical Engineering and in Physics. Afterward, I work at Harris Stratex Corporation as a quality control engineer in electronics manufacturing. I entered graduate school in 2007 at The University of Texas, MD Anderson Cancer Center where I earned a Ph.D. in Medical Physics.
I work on the early research and development of biomedical technology. I am primarily interested in the intersection of Physics, Electrical Engineering, and Biomedical Engineering. My objective is to develop new medical and electronic technologies, especially in biomedical imaging, and improve the diagnosis and treatment of disease. -
Laura Attardi
Professor of Radiation Oncology (Radiation Biology) and of Genetics
Current Research and Scholarly Interests Our research is aimed at defining the pathways of p53-mediated apoptosis and tumor suppression, using a combination of biochemical, cell biological, and mouse genetic approaches. Our strategy is to start by generating hypotheses about p53 mechanisms of action using primary mouse embryo fibroblasts (MEFs), and then to test them using gene targeting technology in the mouse.
-
Magdalena Bazalova
Instructor, Radiation Oncology - Radiation Physics
Current Research and Scholarly Interests I am interested in ) treatment planning for small animal radiotherapy, 2) x-ray fluorescence CT (XFCT) imaging for high-sensitivity molecular imaging, and 3) novel concept of radiation therapy with very high-energy electron (VHEE) beams.
-
Margot Bowen
Postdoctoral Research fellow, Radiation Biology
Current Research and Scholarly Interests Studying the role of the p53 tumor suppressor in embryonic development
-
Martin Brown
Professor of Radiation Oncology, Emeritus
Current Research and Scholarly Interests We seek to understand the mechanisms responsible for the resistance of cancers to treatment and to develop strategies to overcome these resistances. We are using molecular and cellular techniques and mouse models to potentiate the activity of radiation on tumors by inhibiting the bone marrow rescue of the tumor vasculature following therapy.
